Literature DB >> 25952565

A new role for α-synuclein in Parkinson's disease: Alteration of ER-mitochondrial communication.

Cristina Guardia-Laguarta1, Estela Area-Gomez2, Eric A Schon2,3, Serge Przedborski1.   

Abstract

Familial cases of Parkinson's disease (PD) can be associated with overexpression or mutation of α-synuclein, a synaptic protein reported to be localized mainly in the cytosol and mitochondria. We recently showed that wild-type α-synuclein is not present in mitochondria, as previously thought, but rather is located in mitochondrial-associated endoplasmic reticulum membranes. Remarkably, we also found that PD-related mutated α-synuclein results in its reduced association with mitochondria-associated membranes, coincident with a lower degree of apposition of endoplasmic reticulum with mitochondria and an increase in mitochondrial fragmentation, as compared with wild-type. This new subcellular localization of α-synuclein raises fundamental questions regarding the relationship of α-synuclein to mitochondria-associated membranes function, in both normal and pathological states. In this article, we attempt to relate aspects of PD pathogenesis to what is known about mitochondria-associated membranes' behavior and function. We hypothesize that early events occurring in dopaminergic neurons at the level of the mitochondria-associated membranes could cause long-term disturbances that lead to PD.
© 2015 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  MAM; Parkinson's Disease; α-synuclein

Mesh:

Substances:

Year:  2015        PMID: 25952565     DOI: 10.1002/mds.26239

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  36 in total

Review 1.  Calcium, mitochondrial dysfunction and slowing the progression of Parkinson's disease.

Authors:  D James Surmeier; Glenda M Halliday; Tanya Simuni
Journal:  Exp Neurol       Date:  2017-08-02       Impact factor: 5.330

Review 2.  Selective neuronal vulnerability in Parkinson disease.

Authors:  D James Surmeier; José A Obeso; Glenda M Halliday
Journal:  Nat Rev Neurosci       Date:  2017-01-20       Impact factor: 34.870

Review 3.  Mitochondria-ER Tethering in Neurodegenerative Diseases.

Authors:  Reza Raeisossadati; Merari F R Ferrari
Journal:  Cell Mol Neurobiol       Date:  2020-11-16       Impact factor: 5.046

Review 4.  Mitochondria-lysosome crosstalk in GBA1-associated Parkinson's disease.

Authors:  M Sahyadri; Abhishek P R Nadiga; Seema Mehdi; K Mruthunjaya; Pawan G Nayak; Vipan K Parihar; S N Manjula
Journal:  3 Biotech       Date:  2022-08-18       Impact factor: 2.893

Review 5.  Current perspective of mitochondrial biology in Parkinson's disease.

Authors:  Navneet Ammal Kaidery; Bobby Thomas
Journal:  Neurochem Int       Date:  2018-03-14       Impact factor: 3.921

6.  Monoallelic and Biallelic Variants in EMC1 Identified in Individuals with Global Developmental Delay, Hypotonia, Scoliosis, and Cerebellar Atrophy.

Authors:  Tamar Harel; Gozde Yesil; Yavuz Bayram; Zeynep Coban-Akdemir; Wu-Lin Charng; Ender Karaca; Ali Al Asmari; Mohammad K Eldomery; Jill V Hunter; Shalini N Jhangiani; Jill A Rosenfeld; Davut Pehlivan; Ayman W El-Hattab; Mohammed A Saleh; Charles A LeDuc; Donna Muzny; Eric Boerwinkle; Richard A Gibbs; Wendy K Chung; Yaping Yang; John W Belmont; James R Lupski
Journal:  Am J Hum Genet       Date:  2016-03-03       Impact factor: 11.025

Review 7.  Parkinson's Disease Is Not Simply a Prion Disorder.

Authors:  D James Surmeier; José A Obeso; Glenda M Halliday
Journal:  J Neurosci       Date:  2017-10-11       Impact factor: 6.167

Review 8.  Mitochondria-Associated Membranes (MAMs): Overview and Its Role in Parkinson's Disease.

Authors:  M Rodríguez-Arribas; S M S Yakhine-Diop; J M Bravo-San Pedro; P Gómez-Suaga; R Gómez-Sánchez; G Martínez-Chacón; J M Fuentes; R A González-Polo; M Niso-Santano
Journal:  Mol Neurobiol       Date:  2016-10-06       Impact factor: 5.590

Review 9.  Gut Microbial Metabolites in Parkinson's Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment.

Authors:  Yixuan Liang; Li Cui; Jiguo Gao; Mingqin Zhu; Ying Zhang; Hong-Liang Zhang
Journal:  Mol Neurobiol       Date:  2021-04-06       Impact factor: 5.590

Review 10.  Alpha-synuclein research: defining strategic moves in the battle against Parkinson's disease.

Authors:  Luis M A Oliveira; Thomas Gasser; Robert Edwards; Markus Zweckstetter; Ronald Melki; Leonidas Stefanis; Hilal A Lashuel; David Sulzer; Kostas Vekrellis; Glenda M Halliday; Julianna J Tomlinson; Michael Schlossmacher; Poul Henning Jensen; Julia Schulze-Hentrich; Olaf Riess; Warren D Hirst; Omar El-Agnaf; Brit Mollenhauer; Peter Lansbury; Tiago F Outeiro
Journal:  NPJ Parkinsons Dis       Date:  2021-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.